Member Info for neilrich3

No one wants another pandemic—but bird flu has already flown the coop

https://fortune.com/2024/06/11/pandemic-bird-flu-h5n1-spread-health/?abc123

Hoping to see more of these type announcements:

Five-year contract extension with Illumina

https://www.voxmarkets.co.uk/rns/announcement/adbd3c7b-f6f8-463a-a2b0-6bee8b90cedb/?utm_content=258553181&utm_medium=social&utm_source=linkedin&hss_channel=lcp-5097316

Novacyt had been keen to establish itself within the clinical arena, it has achieved this through the takeover. Oliver raises a valid point, why bother if NCYT was simply being run for the Chairman's +£70k take-home pay. Clearly, the likes of Steve Gibson and James McCarthy would have appreciated the potential through their due diligence, I've a lot of time for Steve Gibson and they've already stated that he was instrumental in the takeover of Yourgene Health, it is Steve that's now in charge of the financial affairs.

It has been suggested that sales are taking off within APAC, specifically India. Clearly YourGene has become an established brand, within genomic medicine, plus offices in Singapore, Canada, USA and Taiwan. I notice that upon LinkedIn YourGene has three times as many followers as Novacyt.

The Pacbio event in Thailand appears to have been a success, hopefully this shall translate to new sales, but who knows!

https://www.linkedin.com/posts/patterson-yeoh-25086347_lightbench-revio-sizeselection-activity-7206927801260658688-J0r3?utm_source=share&utm_medium=member_desktop

Not to mention some talented staff.

How messy would that have been, should Yourgene have gone into receivership, we'd still be picking up the pieces and business/customers would have been lost.

Not convinced that the Yourgene acquisition was poorly timed, I'd argue that we are stronger Today than twelve months ago. Novacyt had been attempting to establish a clinical arm, they've done that, 'lock, stock and barrel,' through the acquisition of Yourgene Health. Also, the cloud that was the DHSC dispute has gone and we have still have cash at the bank.

The two previous CEO lacked the required dynamism, the 'get up and go,' in my opinion. I'm not saying that Lyn Rees doesn't have his faults, however he appears far more dynamic with greater visibility, he's attending science/trade events and meeting his customers, the same goes for Joanne Mason. I'm also impressed by Darren Marjenberg, an expert in his field.

I too would love to learn what came of the millions spent upon R&D, I wonder whether we are about to find out, did they keep developments under wraps due to the then ongoing dispute. I'd like know what's happening within the North East at IT-IS International, how many instruments do they manufacture each week and how many are being sold? NIPT appears an interesting market, one worth billions, it might be costly, however I'd hope associated strong returns. Interesting that the United Kingdom remains the largest market for the group, previously Yourgene Health has been awarded DHSC contracts, I'm sure that the door remains open for the correct products and services.

The dispute is yesterday’s news, what’s done is done, need to look forward and be positive about the future potential. The future now being more important than the past. Thankfully, already have annual turnover in the region of £20m, £35m cash at the bank, importantly an established Global footprint with offices in Asia and the Americas.

Testing is going nowhere!

They won’t expand any further upon the details surrounding the dispute, the settlement shall remain confidential…..perhaps in 100 years, the details may come to light.

Clearly the ongoing dispute has been a shackle around the neck of Novacyt, this undoubtedly will have affected their ability to do business. I think that Yourgene has also been affected by their financial woes and their need to regularly raise capital.

Now that both companies have been released from their shackles, who knows, but surely a greater chance of landing some larger contracts. You could argue that until yesterday, business continuity had been in doubt for both, organisations perhaps reluctant to hand either a £5m contract.

Https://www.linkedin.com/posts/yourgene-health_rangertechnology-dna-sizeselection-activity-7206566427846193152-vfii?utm_source=share&utm_medium=member_desktop

Interesting to note that they've expanded their portfolio this past 12 months

Thought that the £5m would be paid from the cash, although not an accountant

Thanks for confirming Exmex, that plus the VAT should boost the balance sheet.

Any thoughts update upon the £20m that Novacyt had put aside, the cost of having to replace product, they’d planned to offer a replacement under warranty.

I'll be there Tomorrow and Weds.....good luck all

Amers, Is there a dress code, jeans and trainers allowed?

Hope JW not attempting bribe the judge with donuts

Amers, What time did you arrive at court? I'm assuming that you're required to be there from the start.

Perhaps both parties are outside of the court doing a deal, settlement upon the steps, it may still happen.

Thanks, but not really, looking for something more specific.

Can't find any detail with regards public access to the trial, does anyone have a link? Is it simply turn up on the day?